Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa
- 1 June 1992
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 102 (6) , 2155-2160
- https://doi.org/10.1016/0016-5085(92)90348-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapyCancer, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitisHepatology, 1989
- INDUCTION OF HYPERTHYROIDISM BY INTERFERON-α-2bThe Lancet, 1989
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis BGastroenterology, 1988
- Hypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer CellsNew England Journal of Medicine, 1988
- Thyroid Autoimmunity in Patients on Long Term Therapy with Leukocyte-Derived Interferon*Journal of Clinical Endocrinology & Metabolism, 1986
- PRIMARY HYPOTHYROIDISM ASSOCIATED WITH INTERFERON THERAPY OF BREAST CANCERThe Lancet, 1985